| Adjuvant therapy | AT |
| Allele frequency | AF |
| Breast imaging-reporting and data system | BIRADS |
| Cell-free DNA | cfDNA |
| Circulating tumor cells | CTCs |
| Circulating tumor DNA | ctDNA |
| Confidence interval | CI |
| Cyclin-dependent kinase 4/6 | CDK4/6 |
| Disease free survival | DFS |
| Distant disease-free survival | DDFS |
| Hazard ratio | HR |
| Minimal residual disease | MRD |
| Multi-cancer early detection | MCED |
| Neoadjuvant chemotherapy | NAT |
| Non-pathologic complete response | non-pCR |
| Overall survival | OS |
| Poly-ADP ribose polymerase | PARP |
| Polymerase chain reaction | PCR |
| Positive predictive value | PPV |
| Triple-negative breast cancer | TNBC |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.